All Hot News World. Public world blog, journal online reviewed.

Research & Development «RealWire»

RSS feed: Research & Development «RealWire»
Tue, 16 Apr 2019 10:00:00 +0100
biotech-research & development feed from realwire
Most recent 15 biotech-research & development articles distributed by realwire [ + ]
Mon, 18 Feb 2019 09:30:00 +0100
Worldwide first and only shotgun lipidomics service provider with official GMP certificate
Dresden / Germany, 16th April 2019 Good Manufacturing Practices (GMP) ensure safety and quality of pharmaceutical products. Lipotype is the worldwide first and only officially GMP certified shotgun lipidomics service provider for pharmaceutical applications. Quality variations can pose direct threats to patient health – especially in the pharma industry. This is why quality control plays a central role in manufacturing and developing pharmaceutical products. GMP certifications are issued by governmental authorities to ensure product quality... Source: RealWire [ + ]
Tue, 05 Feb 2019 09:00:00 +0100
Senior Experts from WHO, HPRA, Wellcome Trust, Centauri Therapeutics to present at 21st Annual Superbugs & Superdrugs Conference in 4 weeks’ time
In just 4 weeks’ time, SMi's 21st Annual Superbugs & Superdrugs Conference will kick off in London, setting out to provide an international audience with key updates on the latest developments in combating antibiotic resistance, including the processes and strategies pharmaceuticals use to develop novel therapeutics that utilise alternative mechanisms to treat multi-drug resistant infections.In the run up to the conference, SMi caught up with this year’s co-chair Lloyd Czaplewski, Director at Chemical Biology Ventures,... Source: RealWire [ + ]
Wed, 16 Jan 2019 11:00:00 +0100
Jennewein Biotechnologie and Yili Group join forces in China for microbiome research and human milk oligosaccharides to bring innovation to the largest baby food market
China represents the largest market for baby food globallyHuman milk oligosaccharides are key for the development of a healthy infant microbiomeHohhot, China & Rheinbreitbach, Germany – Jennewein Biotechnologie GmbH, the global leader in the research and manufacture of human milk oligosaccharides (HMO), and Inner Mongolia Yili Industrial Group (Yili Group), China’s leading dairy company, announce today the signing of a Memorandum of Understanding on infant microbiome and human milk oligosaccharides, with the goal to develop... Source: RealWire [ + ]
Tue, 11 Sep 2018 15:02:00 +0100
Lipotype announces “Lipidomics Excellence Award” for Breakthrough Lipidomics Projects
Call for Applications open till 30 March, 2019Dresden/Germany, 16 January, 2019. The international scientific community is called to submit applications for the premiere of the world’s first award for cutting edge contributions to the progress of life sciences through lipidomics, the 2019 “Lipidomics Excellence Award” (LEA) until 30 March, 2019. Prof. Dr. Kai Simons, Professor and Director Emeritus at Max-Planck-Institute for Molecular Cell Biology and Genetics Dresden and Founder and CEO of Lipotype, explains: “Blood... Source: RealWire [ + ]
Tue, 31 Jul 2018 11:06:00 +0100
PAREXEL Advances Patient-Centric Drug Development with Introduction of its Patient Innovation Center
BOSTON, September 11, 2018 – PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today announced the launch of its Patient Innovation Center, designed to help guide sponsors in their efforts to improve efficiency and success across all areas of biopharmaceutical development including clinical trial design, recruitment, execution and market access. With a patient-centric approach, the Center can help sponsors improve the drug development process by reducing the practical, financial and geographical barriers patients... Source: RealWire [ + ]
Wed, 21 Feb 2018 12:06:00 +0100
LANSA Raises Bar for Low-Code Software Development with New Release of Visual LANSA
London, UK - 31 July 2018 - LANSA (, the original low-code vendor, has announced a major new release of its software development platform, Visual LANSA. This raises the enterprise app development bar by delivering the ability to build scalable mobile, web and desktop applications significantly faster than before.This latest release will accelerate customers’ digital transformation projects, from disruptive customer apps to critical line-of-business solutions. Visual LANSA developers now have access to a range of... Source: RealWire [ + ]
Mon, 12 Feb 2018 14:08:00 +0100
BD Launches Circulating Cell-Free DNA Blood Collection Tube for Cancer and Non-Invasive Prenatal Testing Applications
CE-IVD labeled PAXgene® Blood ccfDNA tube will be available in Western Europe FRANKLIN LAKES, N.J. and EYSINS, SWITZERLAND, February 21, 2018 – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the commercial availability of the CE-IVD marked PAXgene® Blood ccfDNA tube within the European Economic Area and Switzerland (Western Europe). The plastic blood collection tube, which includes a proprietary sample stabilization additive and BD Vacutainer® Hemogard™ technology to... Source: RealWire [ + ]
Mon, 18 Dec 2017 15:16:00 +0100
PAREXEL Introduces Biological Sample Lifecycle Management Service to Address Growing Demand Across Drug Development
Solution combines global laboratory logistics expertise with leading sample tracking software to optimize the management and care of human biological samples throughout their lifecycleBOSTON, February 12, 2018 – PAREXEL International Corporation, the world’s leading innovator of biopharmaceutical services, today launched its Biological Sample Lifecycle Management service, enabling optimal use of human biological samples. The new service enables biopharmaceutical clients to more efficiently manage their often irreplaceable patient biological sample assets from informed consent and collection... Source: RealWire [ + ]
Tue, 12 Dec 2017 14:00:00 +0100
PAREXEL Announces Enhanced Global Data Operations Offering to Drive Efficiencies for Life Science Companies
Solution now features Clinical Metadata Repository to meet evolving data standards while providing seamless and more timely workflow for clients from data collection, through analysis to submissionBOSTON, December 18, 2017 – PAREXEL International Corporation, a leading global biopharmaceutical services provider, today introduced its enhanced Global Data Operations (GDO) solution, with augmented processes and expertise that further bolsters its world leading clinical data services, including data management, statistical programming and biostatistics. The enhanced offering is designed... Source: RealWire [ + ]
Wed, 15 Nov 2017 14:40:00 +0100
PAREXEL Launches Perceptive® Cloud for the Life Sciences Industry
Cloud Platform Built on Microsoft Azure Delivers PAREXEL’s Valued Informatics Solutions on a Global, Trusted Architecture; Represents the First Offering of PAREXEL and Microsoft Alliance BOSTON, December 12, 2017 – PAREXEL International Corporation, a leading global biopharmaceutical services organization, today introduced the Perceptive® Cloud to the life sciences industry, as part of the organization’s recent alliance with Microsoft Corp. Perceptive Cloud elevates PAREXEL Informatics solutions into an enhanced cloud infrastructure built on Microsoft Azure, combining... Source: RealWire [ + ]
Wed, 06 Sep 2017 14:00:00 +0100
PAREXEL Expands Global Regulatory Services with Addition of Senior Executives from FDA and Oncology Industry
New Appointments Enhance PAREXEL’s Leadership and Expertise in Bringing Commercially Viable, Reimbursable Products to MarketBOSTON, November 15, 2017 — PAREXEL, a leading global biopharmaceutical services provider, today announced the appointment of three former senior regulatory consulting executives from the U.S. Food and Drug Administration (FDA) and Oncology industry positions. The new hires are part of PAREXEL’s Global Integrated Product Development and Compliance team and will be focused on helping PAREXEL clients deliver commercially viable, reimbursable... Source: RealWire [ + ]
Tue, 29 Aug 2017 15:00:00 +0100
PAREXEL Launches Real-World Data Service Offering to Drive Value Demonstration of New Treatments
Integrated offering to be provided by new dedicated service group under PAREXEL® AccessBOSTON, September 6, 2017 - PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced that it has launched a new end-to-end service offering to provide real-world data insights that help life science companies more effectively demonstrate product value. “In an increasingly competitive market, leveraging data to demonstrate value is critical. However, unstructured data can make it difficult to overcome... Source: RealWire [ + ]
Mon, 21 Aug 2017 14:37:00 +0100
Peter Rose divulges ins and outs of new MDR at RAPS Regulatory Convergence 2017
Peter Rose will be discussing the intricacies of the new Medical Device Regulation and providing insight for businesses to ensure seamless compliance at this year’s RAPS Regulatory Convergence29 August 2017 – Peter Rose, Managing Director for Maetrics operations in Europe and industry leader will be speaking at the upcoming RAPS Regulatory Convergence in Washington DC about the new Medical Device Regulation (MDR) in Europe. The new regulation has consolidated two existing legal provisions and replaced... Source: RealWire [ + ]
Mon, 19 Jun 2017 13:28:00 +0100
PAREXEL and Osaka International Cancer Institute Form Alliance to Advance Clinical Research in Japan
Alliance to drive greater efficiencies across clinical trials in oncology and hematologyBOSTON and OSAKA, August 21, 2017 – PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, and Osaka International Cancer Institute today announced that they have formed an alliance to advance clinical development in Japan. The partnership will aim to drive greater efficiencies in support of patient recruitment for clinical trials in oncology and hematology, accelerating the development of innovative and effective... Source: RealWire [ + ]

PAREXEL introduces its Connected Journey™ of newly integrated data-driven services to simplify drug development and commercialisation
Features new ForeSite™ clinical trial methodology designed to reliably predict site successLONDON, June 19, 2017 – As life science companies increasingly seek to gain insights from diverse data sources to make drug development more efficient and effective, PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, is launching its Connected Journey™ of data-driven services. This newly integrated network, powered by PAREXEL® Analytics capabilities, combines PAREXEL’s technology, processes, and expertise to deliver critical intelligence... Source: RealWire [ + ]
2013 Copyright © Mobile version 2015 | PeterLife & company
Skimlinks helps publishers monetize editorial content through automated affiliate links for products. Affiliate programm.
Link at is mandatory if site materials are using fully or particulary.
Were treated to the site administrator, a cup of coffee *